The global steerable sheaths market accounted for USD 0.811 billion in 2023 and is expected to reach at USD 1.75 billion by 2034 with a CAGR of 7.26% during the forecast period 2024-2034. The market will grow as a result of factors such as the expanding applications in emerging fields, the growing prevalence of chronic diseases, the rising demand for minimally invasive procedures, technological advancements, and an increase in partnerships and collaborations.
Steerable sheaths that are more advanced and adaptable are being created as a result of ongoing developments in medical technology. These developments include better materials for more control and flexibility, better tip designs for increased maneuverability, and increased precision through integration with imaging technologies. Steerable sheaths' functionality and applications will develop as long as these breakthroughs persist, which will further drive market expansion. For instance, Boston Scientific Corporation introduced the next-generation steerable sheath with greater maneuverability during difficult procedures in August 2023. The sheath has an upgraded tip design.
By type, the single-use steerable sheaths segment accounted for the highest revenue-grossing segment in the global steerable sheaths market in 2023 owing to the growing emphasis on infection control measures, convenience, and cost-effectiveness driving widespread adoption among healthcare providers. For instance, in April 2022, steerable sheaths for negotiating complex anatomy were part of the left heart access portfolio that Acutus Medical had acquired by Medtronic plc. Additionally, the reprocessed steerable sheaths segment is predicted to grow at the fastest CAGR due to the increasing focus on sustainability, cost reduction strategies, and regulatory approvals for reprocessing medical devices.
By application, the electrophysiology procedure segment accounted for the highest revenue-grossing segment in the global steerable sheaths market in 2023 owing to the growing prevalence of cardiac arrhythmias and the expanding applications of steerable sheaths in complex electrophysiology interventions. For instance, Abbott said in February 2023 that the FDA had approved the FreeStyle Libre 2 system for usage in kids and teenagers, extending the technology's market reach for continuous glucose monitoring. Additionally, the interventional cardiology procedure segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising incidence of cardiovascular diseases and increasing adoption of minimally invasive procedures for diagnostic and therapeutic interventions.
By end-user, the hospitals and clinics segment accounted for the highest revenue-grossing segment in the global steerable sheaths market in 2023 owing to the increasing patient admissions, procedural volumes, and investments in advanced medical technologies in healthcare facilities worldwide. For instance, Biosense Webster's CARTO VIZIGOTM Navigation and Ablation Module, which provides cutting-edge solutions for cardiac ablation operations, was approved by the CE Mark in December 2023. Additionally, the ambulatory surgical centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for outpatient procedures, cost-effectiveness, and advancements in ambulatory surgical capabilities and infrastructure.
North American region is anticipated to have the highest revenue share during the forecast period owing to the region's growing prevalence of cardiovascular disorders, its well-established healthcare infrastructure, and its high adoption rates of cutting-edge medical technologies. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding healthcare infrastructure, increasing healthcare expenditure, and rising awareness about advanced treatment options in emerging economies within the region. For instance, in September 2023 Cook Medical unveiled its Hercules® Tissue Anchors for thoracic surgery, offering cutting-edge ways to fix tissue during minimally invasive treatments.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Steerable sheaths that are more advanced and adaptable are being created as a result of ongoing developments in medical technology. These developments include better materials for more control and flexibility, better tip designs for increased maneuverability, and increased precision through integration with imaging technologies. Steerable sheaths' functionality and applications will develop as long as these breakthroughs persist, which will further drive market expansion. For instance, Boston Scientific Corporation introduced the next-generation steerable sheath with greater maneuverability during difficult procedures in August 2023. The sheath has an upgraded tip design.
By type, the single-use steerable sheaths segment accounted for the highest revenue-grossing segment in the global steerable sheaths market in 2023 owing to the growing emphasis on infection control measures, convenience, and cost-effectiveness driving widespread adoption among healthcare providers. For instance, in April 2022, steerable sheaths for negotiating complex anatomy were part of the left heart access portfolio that Acutus Medical had acquired by Medtronic plc. Additionally, the reprocessed steerable sheaths segment is predicted to grow at the fastest CAGR due to the increasing focus on sustainability, cost reduction strategies, and regulatory approvals for reprocessing medical devices.
By application, the electrophysiology procedure segment accounted for the highest revenue-grossing segment in the global steerable sheaths market in 2023 owing to the growing prevalence of cardiac arrhythmias and the expanding applications of steerable sheaths in complex electrophysiology interventions. For instance, Abbott said in February 2023 that the FDA had approved the FreeStyle Libre 2 system for usage in kids and teenagers, extending the technology's market reach for continuous glucose monitoring. Additionally, the interventional cardiology procedure segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising incidence of cardiovascular diseases and increasing adoption of minimally invasive procedures for diagnostic and therapeutic interventions.
By end-user, the hospitals and clinics segment accounted for the highest revenue-grossing segment in the global steerable sheaths market in 2023 owing to the increasing patient admissions, procedural volumes, and investments in advanced medical technologies in healthcare facilities worldwide. For instance, Biosense Webster's CARTO VIZIGOTM Navigation and Ablation Module, which provides cutting-edge solutions for cardiac ablation operations, was approved by the CE Mark in December 2023. Additionally, the ambulatory surgical centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for outpatient procedures, cost-effectiveness, and advancements in ambulatory surgical capabilities and infrastructure.
North American region is anticipated to have the highest revenue share during the forecast period owing to the region's growing prevalence of cardiovascular disorders, its well-established healthcare infrastructure, and its high adoption rates of cutting-edge medical technologies. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding healthcare infrastructure, increasing healthcare expenditure, and rising awareness about advanced treatment options in emerging economies within the region. For instance, in September 2023 Cook Medical unveiled its Hercules® Tissue Anchors for thoracic surgery, offering cutting-edge ways to fix tissue during minimally invasive treatments.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Type, Application, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
Segmentation: Steerable Sheaths Market Report 2023 - 2034
Steerable Sheaths Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Single-use Steerable Sheaths
- Reprocessed Steerable Sheaths
Steerable Sheaths Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Electrophysiology (EP) Procedures
- Interventional Cardiology Procedures
- Peripheral Vascular Procedures
- Other Procedures
Steerable Sheaths Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Others
Steerable Sheaths Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Steerable Sheaths Market: Type Estimates & Trend Analysis
8. Steerable Sheaths Market: Application Estimates & Trend Analysis
9. Steerable Sheaths Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Steerable Sheaths Market
12. Europe Global Steerable Sheaths Market
13. Asia Pacific Global Steerable Sheaths Market
14. Latin America Global Steerable Sheaths Market
15. MEA Global Steerable Sheaths Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Boston Scientific Corporation
- Medtronic plc
- Abbott Laboratories
- Biosense Webster (a Johnson & Johnson company)
- St. Jude Medical (acquired by Abbott Laboratories)
- Biotronik SE & Co. KG
- MicroPort Scientific Corporation
- Merit Medical Systems Inc.
- Teleflex Incorporated
- Cook Medical
- AngioDynamics Inc.
- Terumo Corporation
- CardioFocus Inc.
- Hansen Medical Inc.
- Baylis Medical Company Inc.